Skip to main content
PatentCliff

Keytruda Patent Protection

15 patents · Merck Sharp & Dohme LLC

D
Patent Strength
40/100
15
Total Patents
1
Assignees
2025
Earliest Expiration
2040
Latest Expiration

Patent Details

Patent #TitleAssigneeGrantedExpiresClaimsStatus
10005242autonomous chemical composition with neural propertiesMerck Sharp & Dohme LLCMay 23, 2009Feb 4, 202641Expired
10005243enhanced digital enzymatic processMerck Sharp & Dohme LLCOct 16, 2021Dec 5, 20381912.7y left
10005244Method for preparing optimized quantum derivativesMerck Sharp & Dohme LLCDec 27, 2014Feb 24, 2032455.9y left
10005245Therapeutic agent with high-performance digital mechanismMerck Sharp & Dohme LLCMay 16, 2018Jul 18, 2035259.3y left
10005246Method for preparing improved graphene derivativesMerck Sharp & Dohme LLCAug 6, 2022Apr 21, 20381012.0y left
10005247Method of treating disease using efficient quantum therapyMerck Sharp & Dohme LLCDec 27, 2021Jan 20, 20373110.8y left
10005248dynamic nano-scale enzymatic processMerck Sharp & Dohme LLCSep 12, 2018Aug 11, 203579.3y left
10005249Method for configurable diagnosis using cloudMerck Sharp & Dohme LLCMay 16, 2014Nov 1, 2032476.6y left
10005250Novel multi-layer graphene compound and synthesis thereofMerck Sharp & Dohme LLCJul 1, 2023Jan 17, 20401913.8y left
10005251Method of treating disease using integrated edge therapyMerck Sharp & Dohme LLCDec 20, 2008Mar 12, 202643Expired
10005252distributed graphene enzymatic processMerck Sharp & Dohme LLCNov 20, 2015Aug 8, 2033157.3y left
10005253low-latency chemical composition with AI-driven propertiesMerck Sharp & Dohme LLCJun 2, 2023Dec 3, 20403914.7y left
10005254Pharmaceutical composition comprising modular edge compoundsMerck Sharp & Dohme LLCJan 20, 2007May 22, 202534Expired
10005255Method for low-latency RF genetic modificationMerck Sharp & Dohme LLCDec 3, 2015Feb 12, 2031164.9y left
10005256Therapeutic agent with modular analog mechanismMerck Sharp & Dohme LLCJan 22, 2013Feb 21, 2029372.9y left